| Net (loss) income | |
| Depreciation and amortization | 32.45M |
| Deferred income tax (benefit) expense | -12.43M |
| Provision for doubtful accounts | 108K |
| Share-based compensation | 19.41M |
| Capitalized software write-off | |
| Non-cash restructuring charges | |
| Goodwill impairment | |
| Cash restricted or segregated under regulations and other | |
| Deposits with clearing organizations | |
| Securities owned, at fair value | -2.74M |
| Receivables from brokers, dealers and clearing organizations | |
| Receivables from customers | |
| Accounts payable and accrued expenses | 1.66M |
| Payables to brokers, dealers and clearing organizations | |
| Payables to customers | 17.83M |
| Securities sold, not yet purchased, at fair value | 3.18M |
| Income taxes payable | -9.57M |
| Other, net | -3.45M |
| Net cash (used in) provided by operating activities | |
| Acquisition of subsidiaries, net of acquired cash | |
| Capital purchases | -9.67M |
| Capitalization of software development costs | |
| Proceeds from sale of investments | |
| Net cash used in investing activities | |
| Proceeds from short-term bank loans | |
| Proceeds from (repayments of) term loans | -4.65M |
| Debt issuance costs | -810K |
| Common stock issued | 3.11M |
| Common stock repurchased | -22.11M |
| Shares withheld for net settlements of share-based awards | |
| Net cash provided by (used in) financing activities | |
| Effect of exchange rate changes on cash and cash equivalents | |
| Net decrease in cash and cash equivalents | -69.78M |
| Cash and cash equivalents - beginning of year | 330.65M |
| Cash and cash equivalents - end of period | 260.88M |
| Interest paid | 3.07M |
| Income taxes paid | 12.32M |